Singapore
WEAK demand for its shares has forced drug development firm Cennerv Pharmaceuticals to withdraw its application for an initial public offering (IPO), the company said last week.
The Singapore-based firm had lodged a draft prospectus for a listing on the Catalist board of the Singapore Exchange...